Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Holman

Showing results (571-580 of 716) with videos related to

Pageof 72
Sort By:
Diabetes|July 29, 2006
Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetesSteven E Kahn, Bernard Zinman, Steven M Haffner, et al.
Plos One|July 5, 2013
Discovery of a novel dual fungal CYP51/human 5-lipoxygenase inhibitor: implications for anti-fungal therapyEric K Hoobler, Ganesha Rai, Andrew G S Warrilow, et al.
Scientific Reports|April 19, 2018
Cardiac hypertrophy limits infarct expansion after myocardial infarction in miceSiiri E Iismaa, Ming Li, Scott Kesteven, et al.
The American Journal of Cardiology|January 28, 2014
Effect of cardiac resynchronization therapy on the sequence of mechanical activation assessed by two-dimensional radial strain imagingDominique Auger, Ulas Hoke, Joep Thijssen, et al.
European Heart Journal|June 23, 2010
Time course of global left ventricular strain after acute myocardial infarctionM Louisa Antoni, Sjoerd A Mollema, Jael Z Atary, et al.
Diabetes Care|December 22, 2017
Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a <i>Diabetes Care</i> Editors' Expert ForumWilliam T Cefalu, Sanjay Kaul, Hertzel C Gerstein, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 2005
Reversible diastolic dysfunction after long-term exogenous subclinical hyperthyroidism: a randomized, placebo-controlled studyJ W A Smit, C F A Eustatia-Rutten, E P M Corssmit, et al.
Cardiovascular Diabetology|October 2, 2020
Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors: a multicentre retrospective study (CoViDiab II)Ernesto Maddaloni, Luca D'Onofrio, Francesco Alessandri, et al.
European Journal of Endocrinology|August 3, 2005
Persistent diastolic dysfunction despite successful long-term octreotide treatment in acromegalyS W van Thiel, J J Bax, N R Biermasz, et al.
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|September 13, 2005
Contrast echocardiography as a useful additional diagnostic tool in evaluating a primary cardiac tumorM C P Haverkamp, A J H A Scholte, E R Holman, et al.
Pageof 72

Showing results (571-580 of 716) with videos related to

Sort By:
Pageof 72
Diabetes|July 29, 2006
Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetesSteven E Kahn, Bernard Zinman, Steven M Haffner, et al.
Plos One|July 5, 2013
Discovery of a novel dual fungal CYP51/human 5-lipoxygenase inhibitor: implications for anti-fungal therapyEric K Hoobler, Ganesha Rai, Andrew G S Warrilow, et al.
Scientific Reports|April 19, 2018
Cardiac hypertrophy limits infarct expansion after myocardial infarction in miceSiiri E Iismaa, Ming Li, Scott Kesteven, et al.
The American Journal of Cardiology|January 28, 2014
Effect of cardiac resynchronization therapy on the sequence of mechanical activation assessed by two-dimensional radial strain imagingDominique Auger, Ulas Hoke, Joep Thijssen, et al.
European Heart Journal|June 23, 2010
Time course of global left ventricular strain after acute myocardial infarctionM Louisa Antoni, Sjoerd A Mollema, Jael Z Atary, et al.
Diabetes Care|December 22, 2017
Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a <i>Diabetes Care</i> Editors' Expert ForumWilliam T Cefalu, Sanjay Kaul, Hertzel C Gerstein, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 2005
Reversible diastolic dysfunction after long-term exogenous subclinical hyperthyroidism: a randomized, placebo-controlled studyJ W A Smit, C F A Eustatia-Rutten, E P M Corssmit, et al.
Cardiovascular Diabetology|October 2, 2020
Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors: a multicentre retrospective study (CoViDiab II)Ernesto Maddaloni, Luca D'Onofrio, Francesco Alessandri, et al.
European Journal of Endocrinology|August 3, 2005
Persistent diastolic dysfunction despite successful long-term octreotide treatment in acromegalyS W van Thiel, J J Bax, N R Biermasz, et al.
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|September 13, 2005
Contrast echocardiography as a useful additional diagnostic tool in evaluating a primary cardiac tumorM C P Haverkamp, A J H A Scholte, E R Holman, et al.
Pageof 72